![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.645, 2012-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which cervical cancer screening interval and test is best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 646, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which screening test for diabetes best value in the US?
Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Preventing CMV infection - which strategy's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Reducing the burden of congenital syphilis: which options best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 534, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Measuring indirect costs: which method's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 280, 2000-01 ,pp. :